Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Challenging Behaviors in ASD with Intellectual Disability
NCT05864508Phase 2Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD), sponsored by Centre hospitalier universitaire de Toulouse. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05864508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864508.